China Universal Asset Management »

Pliant Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $173k 12k 14.94
2023-12-31 $125k 6.9k 18.04
2023-09-30 $27k 1.5k 17.66
2023-06-30 $14k 775 18.06
2023-03-31 $21k 773 27.17
2022-12-31 $10k 495 20.20
2022-09-30 $10k 456 21.93

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Pliant Therapeutics

T. Rowe Price Associates
First Light Asset Management
Laurion Capital Management
Vanguard Group
Blue Owl Capital Holdings
Redmile Group
Trv Gp Iv
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Franklin Resources
Casdin Capital
RA Capital Management
Deutsche Bank Aktiengesellschaft
Bessemer
Candriam Luxembourg S.C.A.

View all funds holding Pliant Therapeutics